SICAGEN INDIA LTD. - 533014 - Clarification sought from Sicagen India Ltd
The Exchange has sought clarification from Sicagen India Ltd on September 13, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Sicagen India Ltd - 533014 - Reg. 34 (1) Annual Report
Pursuant to Regulation 34 of the SEBI (LODR) Regulations 2015, We herewith submit the soft copy of 17th Annual Report of the Company for the year 2020-21 along with Notice convening the 17th Annual General Meeting for your records. Sicagen India Ltd - 533014 - 17Th AGM & Book Closure Date
17th Annual General Meeting (AGM) of the Company has been scheduled to be held on Tuesday, the 28/09/2021 at 4.30 p.m. through Video Conferencing. The Register of Members (ROM) Books shall remain closed from 22/09/2021 to 28/09/2021 (both days inclusive) for the purpose of the aforesaid AGM and also ascertaining entitlement of equity dividend payable to the eligible shareholders for FY 2020-21. The equity dividend, if any declared at the aforesaid AGM shall be paid/despatched between 18/10/2021 and 25/10/2021 to the eligible shareholders whose name appear on the ROM/Depositories records as on 21.09.2021 (Record Date). SICAGEN INDIA LTD. - 533014 - Outcome Of Board Meeting
the Board of Directors of the Company at its meeting held today has, inter alia considered the following:- Re-appointment of Mr. R. Chandrasekar, Whole Time Director of the Company for a further period of 3 years w.e.f 28.11.2021 subject to approval of shareholders at the ensuing Annual General Meeting as recommended by the Nomination & Remuneration Committee. Taken on record the resignation of Mr.R.Srikrishna, Company Secretary and Compliance Officer. He has been relieved from the services after serving requisite notice period as per the terms of his appointment. Sicagen India Ltd - 533014 - Unaudited Financial Results For Q1 30.06.2021
the Board of Directors of the Company at its meeting held today has, inter alia considered and approved the following. Unaudited Financial Results of the Company for the quarter ended 30th June 2021. Offer, issue and allot Non-Convertible Preferences Shares of Rs.10 each upto Rs.25,00,00,000 (Rupees Twenty Five Crores Only) under Private Placement basis Sicagen India Ltd - 533014 - Update on board meeting
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve Futher to our earlier intimation dated 26th May 2021, this is to inform pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015 that the Board of Directors of the Company, at the ensuing meeting scheduled to be held on Wednesday, the 11th August 2021, has proposed to consider and and give final approval for fund raising by way of issue of Preference Shares to the extent of Rs.25 Crores under private placement. The proposed issue of Preference Shares shall be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The above information may kindly be taken on record. Sicagen India Ltd - 533014 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30Th June, 2021
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve Unaudited financial results for the quarter ended 30th June, 2021 Sicagen India Ltd - 533014 - Shareholding for the Period Ended June 30, 2021
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here Sicagen India Ltd - 533014 - Update On Voluntary Delisting Of Equity Shares Of The Company From National Stock Exchange Of India Ltd (NSE)
This is to inform that with reference to the application made with National Stock Exchange of India Limited (NSE) for voluntary delisting of equity shares of the company pursuant to the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, the Company has received a letter for Voluntary Delisting of Equity shares of the Company from NSE. As per the NSE letter, the trading in the security will be suspended w.e.f. July 22, 2021 (i.e. w.e.f. closing hours of trading on July 20, 2021). The admission to dealings in the security shall be withdrawn (delisted) w.e.f. July 29, 2021. However, the company will redress the investors' grievances (if any) for a minimum period of one year from the date of delisting. The Equity shares of the Company will remain listed on BSE Limited. SICAGEN INDIA LTD. - 533014 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- R SrikrishnaDesignation :- Company Secretary and Compliance Officer